Compound details
Asn-Trp-Asp-Ser
| Compound ID | CDAMM00209 |
|---|---|
| Common name | Asn-Trp-Asp-Ser | IUPAC name | (3S)-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-[[(2S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoic acid |
| Molecular formula | C22H28N6O9 |
| Retention time | 29.47 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 521.199 | Theoretical mz | 521.199 |
| Error | 0.09 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.3306 |
| Inchi key | WSNSZZGIMVHDHF-TUUVXOQKSA-N |
|---|---|
| Smiles | C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CC(=O)N)N |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00797 | REN | Renin | T61622 | SEA |
| P15144 | ANPEP | Aminopeptidase N | T67272 | SEA |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SEA |
| P08514 | ITGA2B | Integrin alpha-IIb/beta-3 | T50688 | SEA |
| P08473 | MME | Neprilysin | T05409 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| P08235 | NR3C2 | Mineralocorticoid receptor | T72168 | SEA |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SEA |
| P17706 | PTPN2 | T-cell protein-tyrosine phosphatase | T49156 | SEA |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SEA |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SEA |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SEA |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SEA |
| P17655 | CAPN2 | Calpain 2 | T86837 | SEA |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SEA |
| P62993 | GRB2 | Growth factor receptor-bound protein 2 | T30926 | SEA |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SEA |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SEA |
| P09237 | MMP7 | Matrix metalloproteinase 7 | T73475 | SEA |
| P13497 | BMP1 | Bone morphogenetic protein 1 | T53350 | SEA |
| P35270 | SPR | Substance-P receptor | T47094 | SEA |
| P04229 | HLA-DRB1 | HLA class II histocompatibility antigen DRB1-1 | T83611 | SEA |
| P07711 | CTSL | Cathepsin L | T98691 | SEA |
| P32245 | MC4R | Melanocortin receptor 4 | T72458 | SEA |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SEA |
| Q92847 | GHSR | Ghrelin receptor | T59604 | SEA |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SEA |
| Q01726 | MC1R | Melanocortin receptor 1 | T35842 | SEA |
| P41968 | MC3R | Melanocortin receptor 3 | T76846 | SEA |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SEA |
| P29466 | CASP1 | Caspase-1 | T98269 | SEA |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SEA |
| Q6P179 | ERAP2 | Endoplasmic reticulum aminopeptidase 2 | T65818 | SEA |
| P04439 | HLA-A | HLA class I histocompatibility antigen A-3 | T08985 | SEA |
| Q13443 | ADAM9 | ADAM9 | T03672 | SEA |
| P79483 | HLA-DRB3 | HLA class II histocompatibility antigen DRB3-1 | T49146 | SEA |
| P25090 | FPR2 | Lipoxin A4 receptor (by homology) | T97917 | SEA |
| Q9BYF1 | ACE2 | Angiotensin-converting enzyme 2 | T27889 | SEA |
| P42892 | ECE1 | Endothelin-converting enzyme 1 | T50970 | SEA |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SEA |
| P39900 | MMP12 | Matrix metalloproteinase 12 | T03500 | SEA |
| P42574 | CASP3 | Caspase-3 | T57943 | SEA |
| P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor | T15439 | SEA |
| P35346 | SSTR5 | Somatostatin receptor 5 | T64830 | SEA |
| P30874 | SSTR2 | Somatostatin receptor 2 | T53024 | SEA |
| P31391 | SSTR4 | Somatostatin receptor 4 | T62974 | SEA |
| P30872 | SSTR1 | Somatostatin receptor 1 | T16633 | SEA |
| P32745 | SSTR3 | Somatostatin receptor 3 | T13644 | SEA |
| P15085 | CPA1 | Carboxypeptidase A1 | T33966 | SEA |
| P32239 | CCKBR | Cholecystokinin B receptor (by homology) | T05849 | SEA |
| P50281 | MMP14 | Matrix metalloproteinase 14 | T65019 | SEA |
| P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | T40111 | SEA |
| P32238 | CCKAR | Cholecystokinin A receptor | T28330 | SEA |
| Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | T30219 | SEA |
| P28074 | PSMB5 | Proteasome Macropain subunit MB1 | T49031 | SEA |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| P21452 | TACR2 | Neurokinin 2 receptor | T52790 | SEA |
| P09238 | MMP10 | Matrix metalloproteinase 10 | T40488 | SEA |
| P29371 | TACR3 | Neurokinin 3 receptor | T29683 | SEA |
| Q9UIQ6 | LNPEP | Cystinyl aminopeptidase | T97537 | SEA |
| P98073 | TMPRSS15 | Enteropeptidase | T75772 | SEA |
| P28065 | PSMB9 | Proteasome subunit beta type-9 | T06792 | SEA |
| P28062 | PSMB8 | Proteasome subunit beta type-8 | T77350 | SEA |
| P20248 | CCNA2 | CDK2/Cyclin A | T58470 | SEA |
| Q8IU80 | TMPRSS6 | Transmembrane protease serine 6 | T13863 | SEA |
| Q9Y5Y6 | ST14 | Matriptase | T31543 | SEA |
| P51511 | MMP15 | Matrix metalloproteinase 15 | T81658 | SEA |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SEA |
| Q96DB2 | HDAC11 | Histone deacetylase 11 | T97903 | SEA |
| P33032 | MC5R | Melanocortin receptor 5 | T95302 | SEA |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SEA |
| P06734 | FCER2 | Immunoglobulin epsilon Fc receptor | T67207 | SEA |
| P30550 | GRPR | Gastrin releasing peptide receptor | T99816 | SEA |
| Q969S8 | HDAC10 | Histone deacetylase 10 | T94324 | SEA |
| Q9H2K8 | TAOK3 | Serine/threonine-protein kinase TAO3 | T63682 | SEA |
| P07288 | KLK3 | Prostate specific antigen | T36935 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| P21462 | FPR1 | Formyl peptide receptor 1 | T87831 | SEA |
| O95931 | CBX7 | Chromobox protein homolog 7 | T72319 | SEA |
| P23284 | PPIB | Cyclophilin B | T25847 | SEA |
| Q04756 | HGFAC | Hepatocyte growth factor activator | T38584 | SEA |
| O60235 | TMPRSS11D | Transmembrane protease serine 11D | T00302 | SEA |
| P09958 | FUR | HUMAN dibasic-processing enzyme | T98945 | SEA |
| P29120 | PCSK1 | Neuroendocrine convertase 1 | T36445 | SEA |
| Q92824 | PCSK5 | Proprotein convertase subtilisin/kexin type 5 | T38581 | SEA |
| Q06609 | RAD51 | DNA repair protein RAD51 homolog 1 | T63083 | SEA |
| Q9Y4G9 | PCSK6 | Proprotein convertase subtilisin/kexin type 6 | T86503 | SEA |
| P04632 | CAPNS1 | HUMAN calpain-1 or calpain small subunit 1 heterodimer | T00099 | SEA |
| O60603 | TLR2 | Toll-like receptor 2 | T82078 | SEA |
| P05106 | ITGB3 | Integrin beta-3 | T26457 | SEA |
| P42263 | GRIA3 | Glutamate receptor AMPA 3 | T62391 | SEA |
| Q16348 | PEPT2 | Solute carrier family 15 member 2 | T52067 | SEA |
| O95622 | ADCY5 | Adenylate cyclase type 5 | T19531 | SEA |
| Q9HAN5 | TRP1 | Cationic trypsinogen | T27602 | SEA |
| P24347 | MMP11 | Matrix metalloproteinase-11 | T73180 | SEA |
| P05981 | HPN | Serine protease hepsin | T73471 | SEA |
| Q9ULZ9 | MMP17 | Matrix metalloproteinase-17 | T55616 | SEA |
| Q96T53 | FKSG89 | Ghrelin O acyltransferase | T45228 | SEA |
| P55211 | CASP9 | Caspase-9 | T93903 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T61622 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P00797 | REN |
| T67272 | DI0351 | Psoriasis | [ICD-11: EA90] | P15144 | ANPEP |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T50688 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P08514 | ITGA2B |
| T50688 | DI0030 | Angina pectoris | [ICD-11: BA40] | P08514 | ITGA2B |
| T50688 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08514 | ITGA2B |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T72168 | DI0018 | Adrenocortical insufficiency | [ICD-11: 5A74] | P08235 | NR3C2 |
| T72168 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P08235 | NR3C2 |
| T72168 | DI0100 | Contraceptive management | [ICD-11: QA21] | P08235 | NR3C2 |
| T72168 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08235 | NR3C2 |
| T72168 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08235 | NR3C2 |
| T72168 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P08235 | NR3C2 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T49156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P17706 | PTPN2 |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T86837 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P17655 | CAPN2 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T30926 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P62993 | GRB2 |
| T30926 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P62993 | GRB2 |
| T30926 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P62993 | GRB2 |
| T30926 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P62993 | GRB2 |
| T30926 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P62993 | GRB2 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T73475 | DI0238 | Lung cancer | [ICD-11: 2C25] | P09237 | MMP7 |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T83611 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04229 | HLA-DRB1 |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T72458 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | P32245 | MC4R |
| T72458 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P32245 | MC4R |
| T72458 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P32245 | MC4R |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T59604 | DI0087 | Chronic pain | [ICD-11: MG30] | Q92847 | GHSR |
| T59604 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | Q92847 | GHSR |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T35842 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | Q01726 | MC1R |
| T35842 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | Q01726 | MC1R |
| T76846 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P41968 | MC3R |
| T76846 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P41968 | MC3R |
| T76846 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P41968 | MC3R |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T03672 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q13443 | ADAM9 |
| T49146 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P79483 | HLA-DRB3 |
| T49146 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P79483 | HLA-DRB3 |
| T49146 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P79483 | HLA-DRB3 |
| T49146 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P79483 | HLA-DRB3 |
| T97917 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P25090 | FPR2 |
| T27889 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q9BYF1 | ACE2 |
| T27889 | DI0217 | Intrathoracic organs injury | [ICD-11: NB32] | Q9BYF1 | ACE2 |
| T27889 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | Q9BYF1 | ACE2 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T03500 | DI0037 | Asthma | [ICD-11: CA23] | P39900 | MMP12 |
| T03500 | DI0238 | Lung cancer | [ICD-11: 2C25] | P39900 | MMP12 |
| T03500 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P39900 | MMP12 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T15439 | DI0431 | Vasculitis | [ICD-11: 4A44] | P21730 | C5AR1 |
| T64830 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P35346 | SSTR5 |
| T53024 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30874 | SSTR2 |
| T53024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P30874 | SSTR2 |
| T53024 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30874 | SSTR2 |
| T62974 | DI0087 | Chronic pain | [ICD-11: MG30] | P31391 | SSTR4 |
| T62974 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P31391 | SSTR4 |
| T16633 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30872 | SSTR1 |
| T16633 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P30872 | SSTR1 |
| T13644 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P32745 | SSTR3 |
| T05849 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P32239 | CCKBR |
| T05849 | DI0327 | Pancreatic internal secretion disorder | [ICD-11: 5A4Y] | P32239 | CCKBR |
| T65019 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P50281 | MMP14 |
| T40111 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P20839 | IMPDH1 |
| T40111 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P20839 | IMPDH1 |
| T40111 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P20839 | IMPDH1 |
| T40111 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P20839 | IMPDH1 |
| T40111 | DI0413 | Transplant rejection | [ICD-11: NE84] | P20839 | IMPDH1 |
| T28330 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P32238 | CCKAR |
| T28330 | DI0328 | Pancreatic malfunction | [ICD-11: DC30-DC3Z] | P32238 | CCKAR |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T52790 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P21452 | TACR2 |
| T29683 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P29371 | TACR3 |
| T77350 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P28062 | PSMB8 |
| T58470 | DI0363 | Retina cancer | [ICD-11: 2D02] | P20248 | CCNA2 |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T95302 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P33032 | MC5R |
| T95302 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P33032 | MC5R |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T67207 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P06734 | FCER2 |
| T99816 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P30550 | GRPR |
| T99816 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P30550 | GRPR |
| T99816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P30550 | GRPR |
| T94324 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q969S8 | HDAC10 |
| T36935 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P07288 | KLK3 |
| T36935 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P07288 | KLK3 |
| T36935 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P07288 | KLK3 |
| T87831 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P21462 | FPR1 |
| T25847 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P23284 | PPIB |
| T98945 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P09958 | FUR |
| T63083 | DI0048 | B-cell lymphoma | [ICD-11: 2A86] | Q06609 | RAD51 |
| T63083 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06609 | RAD51 |
| T00099 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P04632 | CAPNS1 |
| T82078 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O60603 | TLR2 |
| T62391 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42263 | GRIA3 |
| T27602 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q9HAN5 | TRP1 |
| T27602 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9HAN5 | TRP1 |
| T45228 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q96T53 | FKSG89 |
| T45228 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q96T53 | FKSG89 |
| T93903 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P55211 | CASP9 |